secwatch / observer
8-K filed January 23, 2025, 6:59 PM ET ticker GBCS CIK 0000727346
leadership confidence high sentiment neutral materiality 0.40

CFO James Creamer resigns; CEO Adam Desmond named interim CFO

SELECTIS HEALTH, INC.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Adam Desmond

Chief Financial Officer
GBCS · SELECTIS HEALTH, INC.
Effective
2025-01-17
Filed
January 23, 2025, 6:59 PM ET
Adam Desmond, the Company’s current CEO, will serve as the Interim CFO until a permanent CFO is identified.
Departed

James Creamer

Chief Financial Officer
GBCS · SELECTIS HEALTH, INC.
Effective
2025-01-17
Successor
Adam Desmond
Filed
January 23, 2025, 6:59 PM ET
On January 17, 2025, James Creamer tendered his resignation as Chief Financial Officer of Selectis Health, Inc. (the “Company”), pursuant to a Separation Agreement and Release of even date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Adam Desmond was appointed as Chief Financial Officer at SELECTIS HEALTH, INC..

Action
appointed
Role
Chief Financial Officer
Exact text from the filing
Adam Desmond, the Company’s current CEO, will serve as the Interim CFO until a permanent CFO is identified.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

James Creamer resigned as Chief Financial Officer at SELECTIS HEALTH, INC..

Action
resigned
Role
Chief Financial Officer
Exact text from the filing
On January 17, 2025, James Creamer tendered his resignation as Chief Financial Officer of Selectis Health, Inc. (the “Company”), pursuant to a Separation Agreement and Release of even date.
View on SEC.gov

SELECTIS HEALTH, INC. filing history →

Source: SEC EDGAR
accession 0001493152-25-003346
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.